454 related articles for article (PubMed ID: 19094980)
1. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
Lotito L; Russo A; Bueno S; Chillemi G; Fogli MV; Capranico G
Eur J Pharmacol; 2009 Jan; 603(1-3):29-36. PubMed ID: 19094980
[TBL] [Abstract][Full Text] [Related]
2. Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.
Alessandri M; Beretta GL; Ferretti E; Mancia A; Khobta A; Capranico G
J Mol Biol; 2004 Mar; 337(2):295-305. PubMed ID: 15003448
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects.
Zhou Y; Gwadry FG; Reinhold WC; Miller LD; Smith LH; Scherf U; Liu ET; Kohn KW; Pommier Y; Weinstein JN
Cancer Res; 2002 Mar; 62(6):1688-95. PubMed ID: 11912141
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulatory networks in Saccharomyces cerevisiae.
Lee TI; Rinaldi NJ; Robert F; Odom DT; Bar-Joseph Z; Gerber GK; Hannett NM; Harbison CT; Thompson CM; Simon I; Zeitlinger J; Jennings EG; Murray HL; Gordon DB; Ren B; Wyrick JJ; Tagne JB; Volkert TL; Fraenkel E; Gifford DK; Young RA
Science; 2002 Oct; 298(5594):799-804. PubMed ID: 12399584
[TBL] [Abstract][Full Text] [Related]
5. Global transcription regulation by DNA topoisomerase I in exponentially growing Saccharomyces cerevisiae cells: activation of telomere-proximal genes by TOP1 deletion.
Lotito L; Russo A; Chillemi G; Bueno S; Cavalieri D; Capranico G
J Mol Biol; 2008 Mar; 377(2):311-22. PubMed ID: 18272174
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.
Desai SD; Li TK; Rodriguez-Bauman A; Rubin EH; Liu LF
Cancer Res; 2001 Aug; 61(15):5926-32. PubMed ID: 11479235
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.
Beidler DR; Cheng YC
Mol Pharmacol; 1995 May; 47(5):907-14. PubMed ID: 7538195
[TBL] [Abstract][Full Text] [Related]
8. Meiosis-specific regulation of the Saccharomyces cerevisiae S-phase cyclin CLB5 is dependent on MluI cell cycle box (MCB) elements in its promoter but is independent of MCB-binding factor activity.
Raithatha SA; Stuart DT
Genetics; 2005 Mar; 169(3):1329-42. PubMed ID: 15654101
[TBL] [Abstract][Full Text] [Related]
9. A study of biochemical and functional interactions of Htl1p, a putative component of the Saccharomyces cerevisiae, Rsc chromatin-remodeling complex.
Florio C; Moscariello M; Ederle S; Fasano R; Lanzuolo C; Pulitzer JF
Gene; 2007 Jun; 395(1-2):72-85. PubMed ID: 17400406
[TBL] [Abstract][Full Text] [Related]
10. High functional overlap between MluI cell-cycle box binding factor and Swi4/6 cell-cycle box binding factor in the G1/S transcriptional program in Saccharomyces cerevisiae.
Bean JM; Siggia ED; Cross FR
Genetics; 2005 Sep; 171(1):49-61. PubMed ID: 15965243
[TBL] [Abstract][Full Text] [Related]
11. Refining current knowledge on the yeast FLR1 regulatory network by combined experimental and computational approaches.
Teixeira MC; Dias PJ; Monteiro PT; Sala A; Oliveira AL; Freitas AT; Sá-Correia I
Mol Biosyst; 2010 Dec; 6(12):2471-81. PubMed ID: 20938527
[TBL] [Abstract][Full Text] [Related]
12. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
[TBL] [Abstract][Full Text] [Related]
13. Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.
Chang JY; Liu JF; Juang SH; Liu TW; Chen LT
Cancer Res; 2002 Jul; 62(13):3716-21. PubMed ID: 12097280
[TBL] [Abstract][Full Text] [Related]
14. Rpd3p relocation mediates a transcriptional response to rapamycin in yeast.
Humphrey EL; Shamji AF; Bernstein BE; Schreiber SL
Chem Biol; 2004 Mar; 11(3):295-9. PubMed ID: 15123258
[TBL] [Abstract][Full Text] [Related]
15. Camptothecin resistance involving steps subsequent to the formation of protein-linked DNA breaks in human camptothecin-resistant KB cell lines.
Beidler DR; Chang JY; Zhou BS; Cheng YC
Cancer Res; 1996 Jan; 56(2):345-53. PubMed ID: 8542590
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y
Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753
[TBL] [Abstract][Full Text] [Related]
17. Sin3 is involved in cell size control at Start in Saccharomyces cerevisiae.
Stephan O; Koch C
FEBS J; 2009 Jul; 276(14):3810-24. PubMed ID: 19523118
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin upregulates Saccharomyces cerevisiae genes involved in iron homeostasis through activation of the iron insufficiency-responsive transcription factor Aft1.
Kimura A; Ohashi K; Naganuma A
J Cell Physiol; 2007 Feb; 210(2):378-84. PubMed ID: 17096368
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells.
Ma LC; Kuo CC; Liu JF; Chen LT; Chang JY
Mol Pharmacol; 2008 Aug; 74(2):517-26. PubMed ID: 18492797
[TBL] [Abstract][Full Text] [Related]
20. Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF.
Iyer VR; Horak CE; Scafe CS; Botstein D; Snyder M; Brown PO
Nature; 2001 Jan; 409(6819):533-8. PubMed ID: 11206552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
